Abstract 2637: Novel folate receptor alpha-directed antibody-drug conjugate PRO1184 demonstrates broad antitumor activity with a promising safety profile in preclinical models

抗体-药物偶联物 叶酸受体 癌症研究 卵巢癌 抗体 癌症 医学 单克隆抗体 药理学 癌细胞 化学 内科学 免疫学
作者
Lei Wang,Haidong Liu,Chang Zhou,Tae Young Han,Baiteng Zhao,Zhu Chen
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:83 (7_Supplement): 2637-2637 被引量:2
标识
DOI:10.1158/1538-7445.am2023-2637
摘要

Abstract Folate receptor α (FRα) is overexpressed in a range of solid tumors with limited expression in normal tissues, hence an attractive target for an antibody-drug conjugate (ADC). PRO1184 is comprised of a human monoclonal antibody that selectively binds FRα, a novel cleavable hydrophilic linker, and a topoisomerase 1 inhibitor payload, exatecan. Previous studies established that a) PRO1184 exerts potent antitumor activity in cell-derived xenograft (CDX) models representing ovarian, non-small cell lung, and breast cancer, b) with pharmacokinetics (PK) akin to that of the unconjugated parent antibody in rats, and c) with a preliminary safety profile that was more favorable than a DXd-based ADC in cynomolgus monkeys. Further characterization of the activity and safety of PRO1184 is reported here. PRO1184 displays strong binding affinity, rapid internalization, and potent cytotoxicity with the HCC1954 (breast cancer), JEG-3 (choriocarcinoma), and HEC-1-A (endometrial cancer) cells, in vitro. PRO1184 at a single dose of 5 mg/kg produced marked tumor growth inhibition in CDX models with all three cell lines. In 14 patient-derived xenograft (PDX) models encompassing ovarian, gastric, breast, and non-small cell lung cancer, PRO1184 at a single dose of 5 mg/kg elicited robust antitumor activity in all four tumor types, with ORR and CR accomplished in 10 and 3 out of the 14 models, respectively. Antitumor activity was observed in xenografts with both high and low FRα expression, suggesting that PRO1184 may benefit patients with a wide range of FRα expression. Two DM4-based benchmarking ADCs produced modest to negligible tumor growth inhibition in head-to-head comparisons in the CDX and PDX studies. In a GLP cynomolgus monkey toxicity study for PRO1184, main treatment-related findings were consistent with those associated with exatecan and included reversible gastrointestinal and hematologic toxicities. There were no toxicity findings in lungs, which may translate to a lower risk of interstitial lung disease (ILD) compared to DXd-based ADCs in the clinic. In summary, PRO1184 is a promising development candidate for the treatment of FRα-expressing solid tumors. A first in human phase 1/2 study in patients with advanced solid tumors is currently recruiting (NCT 05579366). Citation Format: Lei Wang, Haidong Liu, Chang Zhou, Tae Han, Baiteng Zhao, Zhu Chen. Novel folate receptor alpha-directed antibody-drug conjugate PRO1184 demonstrates broad antitumor activity with a promising safety profile in preclinical models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2637.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
公孙玲珑完成签到,获得积分10
1秒前
蜗牛星星发布了新的文献求助10
1秒前
stuhwt发布了新的文献求助10
1秒前
天天向上发布了新的文献求助20
2秒前
2秒前
山山而川发布了新的文献求助10
3秒前
万能图书馆的应助被zzk采纳,获得10
3秒前
4秒前
科研通AI6.2的应助被碳点采纳,获得10
5秒前
Orlando完成签到,获得积分20
5秒前
小窝发布了新的文献求助10
5秒前
darkegg发布了新的文献求助10
5秒前
蜗牛星星完成签到,获得积分10
6秒前
7秒前
刻苦夜雪发布了新的文献求助10
7秒前
温赢完成签到 ,获得积分20
7秒前
7秒前
ranran发布了新的文献求助10
7秒前
stuhwt完成签到,获得积分10
8秒前
JamesPei的应助被NAICHA采纳,获得10
8秒前
9秒前
9秒前
ALU完成签到 ,获得积分10
9秒前
9秒前
Blve发布了新的文献求助10
9秒前
科研通AI6.2的应助被chenwen采纳,获得10
9秒前
迷茫的一代完成签到,获得积分0
10秒前
10秒前
10秒前
11秒前
htt发布了新的文献求助10
11秒前
11秒前
陈仙仙发布了新的文献求助10
12秒前
chengqian完成签到 ,获得积分10
12秒前
12秒前
Hello的应助被刻苦夜雪采纳,获得10
13秒前
czy发布了新的文献求助10
13秒前
ft4完成签到,获得积分10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163643
求助须知:如何正确求助?哪些是违规求助? 9557771
关于积分的说明 21741795
捐赠科研通 7754289
什么是DOI,文献DOI怎么找? 3428316
关于科研通互助平台的介绍 2552989
邀请新用户注册赠送积分活动 2472943